Lost password ?
<< Back to Equity Research
Mouwasat Medical
KEEP A CLOSE EYE ON MOUWASAT
Oct 14 - After hitting its all-time high in last April, pushed by strong FY2023 numbers, Mouwasat (Reduce, Saudi Arabia) share price went down in a correction phase triggered by the slowing down growth in Q1 ...
Executive summary
Conflict of Interest
Pages 39
Language English
Publish on October 14, 2024
€ 500
VAT Exl.
You might be also interested by these reports :
Jun 23 PM
Idea Kicker
AKDITAL, FULFILLING ITS PROMISES UNTIL NOW
May 20 PM
Akdital Holding
Strong and fast as expected
May 19 PM
Dallah Healthcare
Softer-than-expected continuing operations' revenue growth in Q1
May 12 PM
Idea Kicker
KNOCKING AT THE DOOR OF MOUWASAT AT 20X PE
FIND A REPORT
CONCEPT
Each company is researched in depth using a structured robust and transparent process.

AlphaMena provides analyses based upon exhaustive and homogeneous information which allows to compare stocks geographically, sector-wise, and by thematic.

The analyses include actuarial as well as off balance-sheet data.
BloombergStarmineFactsetReutersCapital IQ